Science ❯ Medical Research

Oncology

Cancer Treatment Tumor Biology Immunotherapy Diagnostic Techniques Clinical Trials Treatment Innovations Drug Mechanism Therapeutics Cancer Therapies Breast Cancer Studies Hematology Innovative Treatments Cancer Types Melanoma Gene Therapy Genetic Mutations Epidemiology Patient Outcomes Blood Cancers Collaboration Long-term Effects of Treatment mRNA Technology Hormonal Therapy Hair Follicle Biology Breast Cancer Cancer Research Immunotherapy Research Drug Development Biologics Treatment Advances Trial Phases Surgery Carcinogenesis Therapies Voice Disorders Bowel Cancer Studies Clinical Studies Therapeutic Development Therapeutic Vaccines Prostate Cancer Research Brain Cancer Patient Education Computational Oncology Bladder Cancer Research Early Detection Techniques Cancer Detection Prostate Health Rare Tumors Gastroenterology KRAS Mutations Digestive Cancers Lung Cancer Antibody Therapy Blood Cancer Pediatric Oncology Diagnostic Imaging Cancer Prevention Cancer Genetics Pancreatic Cancer Lung Cancer Treatments Cancer Causes Cancer Treatments Preventive Health Prostate Cancer Translational Research Innovations in Cancer Treatment Genetic Abnormalities Cancer Studies Diagnostic Methods Research Management Radiation Therapy Public Health Chondrosarcoma Precision Medicine Tumor Microenvironment Cancer Biology Genetic Testing Cancer Risk Factors Viral Infections Institutional Governance Protein Targeting Cancer Screening Solid Tumors

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

An FDA early-access program has triggered heavy demand that is straining cancer centers.

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

Ben Sasse Reports 76% Tumor Reduction on Experimental Pancreatic Cancer Drug

Global Study Projects Breast Cancer to Exceed 3.5 Million Cases a Year by 2050, With Deaths Near 1.4 Million

Microplastics Detected in Prostate Tumors in Small NYU Study

Zymeworks and BeOne Say Phase 3 Zanidatamab Regimens Top Two Years’ Survival in First-Line HER2+ GEA

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Zymeworks Shifts to Royalty Model After Ziihera’s Phase 3 Win in HER2‑Positive Gastroesophageal Cancer

Viral Clip of Putin’s Hands Revives Health Questions

Lung Cancer Survival Climbs With Earlier Detection as ALA Flags Threats to Progress

Florida Awards $30 Million to Four Children’s Hospitals for Pediatric Cancer Research and Care

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

Serial Biopsies Reveal Responses Missed by MRI in Glioblastoma CAN-3110 Trial

Lobular Breast Cancer Is Rising Fast, Now Over 1 in 10 U.S. Cases

Glioblastoma Erodes the Skull and Alters Immune Marrow, Raising Treatment Cautions

AACR’s 2025 Report Shows Cancer Survival Gains as Early-Onset Cases Climb, Presses for Sustained U.S. Funding

Science Advances Study Identifies Pentose Phosphate Pathway Vulnerability in MPNST

Respiratory Viruses Can Awaken Dormant Cancer Cells via IL-6-Driven Inflammation